Adani Ports breaks out at record Rs 1,747 as 500 MMT milestone meets Hormuz reroute trade (NSE: ADANIPORTS)
Read More Pharma Industry News Can asciminib reshape first-line CML treatment? Inside Scemblix’s rise as a new standard of care in Canada More than a month after Health Canada’s approval, Scemblix is forcing a rethink of chronic myeloid leukemia therapy—and raising the bar for tolerability and precision. byPallavi MadhirajuAugust 31, 2025